ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions
View by Date

Tuesday, November 10, 2015

9:00AM-11:00AM
Abstract Number: 2214
Activation Feature of RANKL/RANK Signaling Pathway in Ankylosing Spondylitis Patients Compared with Healthy People
Biology and Pathology of Bone and Joint: Bone Remodeling and Metabolism
9:00AM-11:00AM
Abstract Number: 2483
Adherence to 2011 American Academy of Ophthalmology Guidelines to Perform Objective Screening Tests for Detection of Antimalarial Retinal Toxicity Is Suboptimal
Quality Measures and Quality of Care Poster Session
9:00AM-11:00AM
Abstract Number: 2508
Adherence to ACR Guidelines in the Management of Lupus Nephritis – a Quality Improvement Initiative
Quality Measures and Quality of Care Poster Session
9:00AM-11:00AM
Abstract Number: 3013
Adipose Loss of Co-Repressor Ncor Attenuates Bleomycin-Induced Skin Fibrosis By Enhancing PPAR-Gamma Signaling
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics Poster II
9:00AM-11:00AM
Abstract Number: 2284
Age and Sex Stratified Normative Data for Shoulder Range of Movement
Epidemiology and Public Health Poster (ARHP)
9:00AM-11:00AM
Abstract Number: 2580
Age-Related Differences in Collagen-Induced Arthritis: Clinical, Imaging and Biological Characteristics in Juvenile Compared to Adult Animals
Rheumatoid Arthritis - Animal Models Poster
9:00AM-11:00AM
Abstract Number: 2331
Agreement Between Patient’s and Physician’s Reported Bath Ankylosing Spondylitis Disease Activity Index in Patients with Axial Spondyloarthritis
Health Services Research Poster III: Patient Reported Outcomes, Patient Education and Preferences
9:00AM-11:00AM
Abstract Number: 10L
Aiming for Remission in Rheumatoid Arthritis: Clinical and Radiographic Outcomes from a Randomized Controlled Strategy Trial Investigating the Added Value of Ultrasonography in a Treat-to-Target Regimen
ACR Late-breaking Abstract Poster Presentations
9:00AM-11:00AM
Abstract Number: 2718
Along Those Lines: Synoviocyte Cell-to-Cell Communication Via Nanotubes
Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster III
9:00AM-11:00AM
Abstract Number: 2552
Alterations in the Colonic Microbiome Precede the Development of Murine Inflammatory Arthritis
Rheumatoid Arthritis - Animal Models Poster
9:00AM-11:00AM
Abstract Number: 2462
Altered Expression of IL-10 Family Cytokines in Chronic Recurrent Multifocal Osteomyelitis Result in Enhanced Inflammasome Activation
Pediatric Rheumatology - Pathogenesis and Genetics Poster
9:00AM-11:00AM
Abstract Number: 2976
Ambrisentan Dose Migration over 3 Years in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension (CTD-PAH)
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster III
9:00AM-11:00AM
Abstract Number: 2741
An Analysis of the Efficacy of Tofacitinib Monotherapy in MTX-Naïve Patients with Early RA Compared with Patients with Established RA
Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy Poster III
9:00AM-11:00AM
Abstract Number: 2494
An Electronic Safety Dashboard for Rheumatology Clinics
Quality Measures and Quality of Care Poster Session
9:00AM-11:00AM
Abstract Number: 2316
An Ethnographic Observational Study of the Biologic Initiation Conversation Between Rheumatologists and Biologic Naïve Rheumatoid Arthritis Patients
Health Services Research Poster III: Patient Reported Outcomes, Patient Education and Preferences
  • «Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 72
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology